[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369853-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369853-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","inhibition-of-acvr1-in-cancer-associated-fibroblasts-suppresses-colorectal-cancer-cell-growth","Inhibition of ACVR1 in Cancer-Associated Fibroblasts Suppresses Colorectal Cancer Cell Growth","","Colorectal cancer (CRC) is a highly lethal malignancy shaped by stromal cancer-associated fibroblasts (CAFs). CRC stromal signatures associate with poor prognosis and chemotherapy resistance, yet effective molecularly targeted therapies for CAFs remain limited. Using two-dimensional organoid cultures and single-cell analysis, the study evaluates cancer–fibroblast crosstalk centered on activin receptor type I (ACVR1) in fibroblasts and bone morphogenetic protein 7 (BMP7) in cancer cells. In stage II CRC, high ACVR1 and BMP7 mark worse survival, and ACVR1 inhibition reduces tumor growth during coculture.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/inhibition-of-acvr1-in-cancer-associated-fibroblasts-suppresses-colorectal-cancer-cell-growth/369853/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/inhibition-of-acvr1-in-cancer-associated-fibroblasts-suppresses-colorectal-cancer-cell-growth/369853.png","ImageObject",300,407,{"name":42,"@type":43},"Franzy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why focus on cancer-associated fibroblasts in colorectal cancer?","Question",{"text":63,"@type":64},"CRC stromal signatures correlate with poor prognosis and resistance to chemotherapy. CAFs also influence tumor development, progression, and relapse through signals in the tumor microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What model and analytical approach were used to study fibroblast heterogeneity?",{"text":68,"@type":64},"The study used two-dimensional organoid (2DO) methods to mimic CRC histology and applied single-cell analysis to examine cancer–fibroblast crosstalk and fibroblast subpopulations.",{"name":70,"@type":61,"acceptedAnswer":71},"How are ACVR1 and BMP7 connected to prognosis and therapeutic targeting?",{"text":72,"@type":64},"The BMP7–ACVR1 axis emerged as a potential therapeutic target. High ACVR1 and BMP7 expression correlated with worse disease-free survival and overall survival in stage II CRC, and ACVR1 inhibitor treatment inhibited tumor growth in coculture.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369853,1790820744,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Ann Surg Oncol (2025) 32:7333–7343  \n[https://doi.org/10.1245/s10434-025-17765-0](https://doi.org/10.1245/s10434-025-17765-0)  \nORIGINAL ARTICLE – COLORECTAL CANCER  \nInhibition of ACVR1 in Cancer‑Associated Fibroblasts Suppresses Colorectal Cancer Cell Growth  \nShinya Kato, M.D1,2, Norikatsu Miyoshi, M.D., Ph.D.1,2, Shiki Fujino, M.D., Ph.D.1,2,3, Masafumi Horie, M.D., Ph.D.4, Shinichi Yachida, M.D., Ph.D.5, Mitsunobu Takeda, M.D., Ph.D.1, Yuki Sekido, M.D., Ph.D.1, Tsuyoshi Hata, M.D., Ph.D.1, Atsushi Hamabe, M.D., Ph.D.1, Takayuki Ogino, M.D., Ph.D.1, Mamoru Uemura, M.D., Ph.D.1, Hirofumi Yamamoto, M.D., Ph.D.1, Masayoshi Yasui, M.D., Ph.D.6, Masayuki Ohue, M.D., Ph.D.6, Yuichiro Doki, M.D., Ph.D.1, and Hidetoshi Eguchi, M.D., Ph.D.1  \n1Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan; 2Innovative Oncology Research and Regenerative Medicine, Osaka International Cancer Institute, Osaka, Japan; 3Colorectal Surgery, Monash Health Dandenong Hospital, Dandenong, Australia; 4Department of Molecular and Cellular Pathology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan; 5Department of Cancer Genome Informatics, Graduate School of Medicine, Osaka University, Osaka, Japan; 6Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan  \nABSTRACT  \nBackground. Colorectal cancer (CRC) is the third most common malignancy worldwide and a leading cause of cancer-related mortality. Stromal signatures in CRC are correlated with poor prognosis and resistance to chemotherapy, affecting tumor progression and relapse. Although singlecell analyses have identified subpopulations of cancerassociated fibroblasts (CAFs), effective molecular targeted therapies against CAFs are lacking.  \nMaterials and Methods. We employed organoid culture methods, focusing on two-dimensional organoids (2DOs) to mimic CRC histology. Using single-cell analysis, we investigated cancer-fibroblast crosstalk, with emphasis on activin receptor type I (ACVR1) in fibroblasts and bone morphogenetic protein 7 (BMP7) in cancer cells as potential therapeutic targets. The correlation between high ACVR1 and BMP7 expression levels and the prognosis of patients with stage II cancer was evaluated.  \nResults. The 2DO mouse xenograft model replicated the characteristics of the fibroblast subpopulations present in  \n© The Author(s) 2025  \nFirst Received: 4 March 2025  \nAccepted: 16 June 2025  \nPublished online: 31 July 2025  \nN. Miyoshi, M.D., Ph.D.  \ne-mail: [nmiyoshi@gesurg.med.osaka-u.ac.jp](nmiyoshi@gesurg.med.osaka-u.ac.jp)  \nhuman CRC tumors. Single-cell RNA sequencing identified fibroblast clusters, with the BMP7–ACVR1 axis emerging as a potential therapeutic target. High BMP7 and ACVR1 expression was significantly correlated with poor diseasefree survival and overall survival in stage II CRC. Administration of an ACVR1 inhibitor during the coculture of 2DOsand mouse stromal cells inhibited tumor growth. Conclusions. ACVR1 is a promising therapeutic target that inhibits CAF proliferation. High BMP7 and ACVR1 expression is a significant prognostic factor in stage II CRC.  \nKeywords ACRV1 · BMP7–ACRV1 axis · Cancerassociated fibroblast · Colorectal cancer · Organoid culture · Tumor growth inhibition · Two-dimensional organoid  \nColorectal cancer (CRC) is the third most prevalent malignancy and the fourth leading cause of cancer-related mortality.1 Stromal signatures of CRC correlate with poor prognosis and resistance to chemotherapy.2 Tumor stroma plays a critical role in tumor development, progression, drug resistance, and relapse.3 The microenvironment of the cancer stroma is composed of fibroblasts, immune cells, blood vessels, and the extracellular matrix (ECM) .4,5 The fibroblasts surrounding cancer cells produce ECM, cytokines, proteases, and growth factors, functioning in either tumor  \npromotion or suppression.6,7 In colorectal cancer, consensus molecular subtype","cbCaiol1jBMmAl2f","https://ap.wps.com/l/cbCaiol1jBMmAl2f","pdf",1911847,"English","# Abstract\n## Background\n## Materials and Methods\n## Results\n## Conclusions\n# Introduction\n## Role of stromal signatures and CAF heterogeneity\n## Rationale for organoid models\n# Materials and Methods\n## Primary culture of 2DOs","[{\"question\":\"Why focus on cancer-associated fibroblasts in colorectal cancer?\",\"answer\":\"CRC stromal signatures correlate with poor prognosis and resistance to chemotherapy. CAFs also influence tumor development, progression, and relapse through signals in the tumor microenvironment.\"},{\"question\":\"What model and analytical approach were used to study fibroblast heterogeneity?\",\"answer\":\"The study used two-dimensional organoid (2DO) methods to mimic CRC histology and applied single-cell analysis to examine cancer–fibroblast crosstalk and fibroblast subpopulations.\"},{\"question\":\"How are ACVR1 and BMP7 connected to prognosis and therapeutic targeting?\",\"answer\":\"The BMP7–ACVR1 axis emerged as a potential therapeutic target. High ACVR1 and BMP7 expression correlated with worse disease-free survival and overall survival in stage II CRC, and ACVR1 inhibitor treatment inhibited tumor growth in coculture.\"}]","Inhibition of ACVR1 in Cancer-Associated Fibroblasts Suppresses Colorectal Cancer Cell Growth | PDF",1790184868,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19f9c5aa98dd341cb368209d26733b37.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9eeb30105d0524b6f0eaaa7c19552797.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba3a90fea8a05e7c13cf863e3ff2d6b8.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c265c0bc5200db547f6e3dd71bd442ef.webp",980,1301]